DFE Pharma

Goch, Germany Founded: 2011 • Age: 15 yrs Acquired By CVC
Developer and manufacturer of excipients for oral solid dosage forms and dry powder inhalations
Request Access

About DFE Pharma

DFE Pharma is a company based in Goch (Germany) founded in 2011 was acquired by CVC in September 2019.. DFE Pharma operates in a competitive market with competitors including Colorcon, SPI Pharma, Pfanstiehl, Meggle Pharma and JRS Pharma, among others.

  • Headquarter Goch, Germany
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    CVC

    (Sep 25, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of DFE Pharma
Headcount 200-500
Employee Profiles 1
Employee Profiles
People
Martti Hedman
Advisor

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of DFE Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in DFE Pharma

DFE Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CVC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Mezzanine financing and equity investments are provided by CVC.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by DFE Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - DFE Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Dfe Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of DFE Pharma

DFE Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Colorcon, SPI Pharma, Pfanstiehl, Meggle Pharma and JRS Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups
domain founded_year HQ Location
Excipient products and formulations are manufactured for pharmaceutical uses.
domain founded_year HQ Location
APIs, injectable excipients, and bioprocessing solutions are manufactured.
domain founded_year HQ Location
Develops and manufactures pharmaceutical excipients for the industry.
domain founded_year HQ Location
Supplies excipients, coatings, and technical services for health sciences worldwide.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Dfe Pharma

Frequently Asked Questions about DFE Pharma

When was DFE Pharma founded?

DFE Pharma was founded in 2011.

Where is DFE Pharma located?

DFE Pharma is headquartered in Goch, Germany. It is registered at Goch, North Rhine-westphalia, Germany.

Who is the current CEO of DFE Pharma?

Martti Hedman is the current CEO of DFE Pharma.

What does DFE Pharma do?

DFE Pharma is engaged in the development, manufacturing, and marketing of excipients for oral solid dosage forms and dry powder inhalation formulations. They offer their services for pharmaceutical companies all over the globe for the development of products and also in improving the performance of existing drugs. The company specializes in proprietary excipients such as microcrystalline cellulose, starch and lactose, while they also develop excipients for dry powder inhalations and superdisintegrants. The company is jointly owned by Royal FrieslandCampina and Fonterra, multinational dairy companies.

Who are the top competitors of DFE Pharma?

DFE Pharma's top competitors include Colorcon, Crest Cellulose and Scope Ingredients.

Who are DFE Pharma's investors?

DFE Pharma has 1 investor. Key investors include CVC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available